Annual Cash & Cash Equivalents
$7.61 M
+$4.17 M+121.63%
December 31, 2023
Summary
- As of February 12, 2025, BDRX annual cash & cash equivalents is $7.61 million, with the most recent change of +$4.17 million (+121.63%) on December 31, 2023.
- During the last 3 years, BDRX annual cash & cash equivalents has fallen by -$2.68 million (-26.03%).
- BDRX annual cash & cash equivalents is now -83.88% below its all-time high of $47.20 million, reached on December 1, 2014.
Performance
BDRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$6.39 M
-$1.21 M-15.95%
June 1, 2024
Summary
- As of February 12, 2025, BDRX quarterly cash and cash equivalents is $6.39 million, with the most recent change of -$1.21 million (-15.95%) on June 1, 2024.
- Over the past year, BDRX quarterly cash and cash equivalents has dropped by -$199.30 thousand (-3.02%).
- BDRX quarterly cash and cash equivalents is now -86.45% below its all-time high of $47.20 million, reached on December 1, 2014.
Performance
BDRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BDRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +121.6% | -3.0% |
| 3 y3 years | -26.0% | +86.3% |
| 5 y5 years | +155.8% | +86.3% |
BDRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.0% | +121.6% | -52.9% | +86.3% |
| 5 y | 5-year | -46.9% | +121.6% | -55.4% | +86.3% |
| alltime | all time | -83.9% | +155.8% | -86.5% | +115.1% |
Biodexa Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $6.39 M(-15.9%) |
| Dec 2023 | $7.61 M(+121.6%) | $7.61 M(+15.4%) |
| Jun 2023 | - | $6.59 M(+92.1%) |
| Dec 2022 | $3.43 M(-74.7%) | $3.43 M(-55.9%) |
| Jun 2022 | - | $7.79 M(-42.6%) |
| Dec 2021 | $13.57 M(+32.0%) | $13.57 M(+133.3%) |
| Jun 2021 | - | $5.82 M(-43.4%) |
| Dec 2020 | $10.28 M(-28.2%) | $10.28 M(+93.0%) |
| Jun 2020 | - | $5.33 M(-62.8%) |
| Dec 2019 | $14.33 M | $14.33 M(+26.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $11.38 M(+282.6%) |
| Dec 2018 | $2.97 M(-83.3%) | $2.97 M(-44.8%) |
| Jun 2018 | - | $5.38 M(-69.8%) |
| Dec 2017 | $17.84 M(-17.5%) | $17.84 M(+121.8%) |
| Jun 2017 | - | $8.05 M(-62.8%) |
| Dec 2016 | $21.63 M(-9.7%) | $21.63 M(+122.4%) |
| Jun 2016 | - | $9.73 M(-59.4%) |
| Dec 2015 | $23.96 M(-49.2%) | $23.96 M(-37.4%) |
| Jun 2015 | - | $38.28 M(-18.9%) |
| Dec 2014 | $47.20 M(+1099.1%) | $47.20 M |
| Dec 2013 | $3.94 M | - |
FAQ
- What is Biodexa Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Biodexa Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Biodexa Pharmaceuticals?
- What is Biodexa Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Biodexa Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of BDRX is $7.61 M
What is the all time high annual cash & cash equivalents for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high annual cash & cash equivalents is $47.20 M
What is Biodexa Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, BDRX annual cash & cash equivalents has changed by +$4.17 M (+121.63%)
What is Biodexa Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BDRX is $6.39 M
What is the all time high quarterly cash and cash equivalents for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals all-time high quarterly cash and cash equivalents is $47.20 M
What is Biodexa Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, BDRX quarterly cash and cash equivalents has changed by -$199.30 K (-3.02%)